Header Logo

Connection

Lerato Mohapi to Intention to Treat Analysis

Back to Details
This is a "connection" page, showing publications Lerato Mohapi has written about Intention to Treat Analysis.
Lerato Mohapi
Connection Strength
0,031
Intention to Treat Analysis
  1. Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study. Lancet Infect Dis. 2015 Jul; 15(7):793-802.
    View in: PubMed
    Score: 0,031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.